Table 3

SNVs and indels found in RAD21 in 170 AML patients

RAD21Mutation typePositionAlleleProteinAML typePolyphenRAS status
Exon 2 Missense chr8: 117878875 G>C p.V32L CN-AML with NPM1 probably_damaging(0.816); wt 
Exon 5 Indel chr8: 117870615 */+GA p.S153fs CN-AML with NPM1 nonsense mut 
Exon 6 Missense chr8: 117869507 A>C p.L229F Other, sAML (45,XX,inv(3)(q21q26),−7) probably_damaging(0.975); mut 
Exon 9 Indel chr8: 117866622 */+TTAG p.S342fs CBF-AML, t(8;21) nonsense mut 
Exon 10 Nonsense chr8: 117864866 G>T p. E415X CN-AML with NPM1 nonsense wt 
Exon 10 Nonsense chr8: 117864815 G>A p.Q432X CK-AML nonsense wt 
Exon 14 Missense chr8: 117859872 C>T p.T588M CBF-AML, inv (16) probably_damaging(0.916); mut 
Exon 7 Synonymous chr8: 117868964 C>T p.P245P CN-AML with NPM1 N/A wt 
Exon 10 Synonymous chr8: 117864840 A>G p. P423P CBF-AML, inv(16) N/A mut 
Exon 11 SNP rs1050838 chr8: 117864217 C>T p.A480A N/A (observed in n = 28 cases) N/A N/A 
RAD21Mutation typePositionAlleleProteinAML typePolyphenRAS status
Exon 2 Missense chr8: 117878875 G>C p.V32L CN-AML with NPM1 probably_damaging(0.816); wt 
Exon 5 Indel chr8: 117870615 */+GA p.S153fs CN-AML with NPM1 nonsense mut 
Exon 6 Missense chr8: 117869507 A>C p.L229F Other, sAML (45,XX,inv(3)(q21q26),−7) probably_damaging(0.975); mut 
Exon 9 Indel chr8: 117866622 */+TTAG p.S342fs CBF-AML, t(8;21) nonsense mut 
Exon 10 Nonsense chr8: 117864866 G>T p. E415X CN-AML with NPM1 nonsense wt 
Exon 10 Nonsense chr8: 117864815 G>A p.Q432X CK-AML nonsense wt 
Exon 14 Missense chr8: 117859872 C>T p.T588M CBF-AML, inv (16) probably_damaging(0.916); mut 
Exon 7 Synonymous chr8: 117868964 C>T p.P245P CN-AML with NPM1 N/A wt 
Exon 10 Synonymous chr8: 117864840 A>G p. P423P CBF-AML, inv(16) N/A mut 
Exon 11 SNP rs1050838 chr8: 117864217 C>T p.A480A N/A (observed in n = 28 cases) N/A N/A 

The chromosomal coordinates refer to the human reference genome hg19 (GRCh37). The predicted effect on protein function was analyzed using the indicated algorithms.

SNV indicates single nucleotide variation; AML, acute myeloid leukemia; RAS, ; chr, chromosome; CN-AML, cytogenetically normal AML; sAML, secondary AML; CBF-AML, core-binding factor AML; CK-AML, complex karyotype AML; fs, frameshift; N/A, not applicable; wt, wild type; and mut, mutated.

Close Modal

or Create an Account

Close Modal
Close Modal